Emergent BioSolutions
EBS
S$8.01
Share price
-1.43%
Change (1 day)
-8.36%
Change (1 year)
Categories
Emergent BioSolutions (EBS) - Net assets
Net assets on the balance sheet as of March 2025 : S$0.71 Billion
According to Emergent BioSolutions
's latest financial reports the company has S$0.71 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $S$0.65 B | -23.47% |
| 2023-12-31 | $S$0.85 B | -53.9% |
| 2022-12-31 | $S$1.86 B | -14.61% |
| 2021-12-31 | $S$2.17 B | 13.81% |
| 2020-12-31 | $S$1.91 B | 30.45% |
| 2019-12-31 | $S$1.46 B | 6.26% |
| 2018-12-31 | $S$1.38 B | 13.18% |
| 2017-12-31 | $S$1.22 B | 41.41% |
| 2016-12-31 | $S$0.86 B | -7.58% |
| 2015-12-31 | $S$0.93 B | 27.72% |
| 2014-12-31 | $S$0.73 B | 17.94% |
| 2013-12-31 | $S$0.61 B | 14.63% |
| 2012-12-31 | $S$0.54 B | 0.18% |
| 2011-12-31 | $S$0.53 B | 12.16% |
| 2010-12-31 | $S$0.48 B | 40.58% |
| 2009-12-31 | $S$0.34 B | 20.06% |
| 2008-12-31 | $S$0.28 B | 15.75% |
| 2007-12-31 | $S$0.24 B | 16% |
| 2006-12-31 | $S$0.21 B | 113.48% |
| 2005-12-31 | $S$99.46 M | 165.66% |
| 2004-12-31 | $S$37.43 M | |
| 2002-12-31 | $S$7.2 M | -112.06% |
| 2001-12-31 | $-S$59.79 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Merck MRK | S$62.31 B | 8,657.01% | 🇺🇸 USA |
 SIGA Technologies SIGA | S$0.27 B | -60.90% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$22.74 B | 3,096.29% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | S$0.90 B | 27.19% | 🇺🇸 USA |
 Pfizer PFE | S$116.68 B | 16,298.95% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | S$8.07 B | 1,034.25% | 🇮🇱 Israel |
 Soligenix SNGX | S$4.65 M | -99.35% | 🇺🇸 USA |